Elucidating the molecular mechanisms that regulate stem cell numbers in vivo

阐明体内调节干细胞数量的分子机制

基本信息

  • 批准号:
    8220768
  • 负责人:
  • 金额:
    $ 35.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-02-01 至 2014-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The molecular mechanisms controlling stem cell self-renewal versus differentiation hold great potential for advances in cancer biology, aging and regenerative medicine. Increasing the pool of stem cells provides a condition for oncogenesis; tumors have "cancer stem cells" that self-renew and establish metastases. A critical regulator of stem cell numbers in mammals is the JAK/STAT pathway. Inappropriate activation of mammalian JAKs and STATs cause cancer and inhibiting their activity blocks the growth of primary human cancer cells. These data suggests that developing drugs which specifically inhibit JAKs or STATs, could offer novel treatments for cancer patients. Despite these compelling observations, the mechanisms utilized by this pathway to regulate stem cell numbers in mammals have not yet been elucidated. Mammals have multiple jak and stat genes, making the analysis of their in vivo function difficult. Drosophila offers an ideal system to address this issue, as its control of stem cell numbers is conserved in several tissues, including the testis and eye. Drosophila has only one jak and one stat (called stat92E) and offers facile in vivo analysis. This application concerns the dissection of molecular mechanisms used by the JAK/STAT pathway to regulate stem cell number in Drosophila. Three distinct processes must occur in a coordinated manner for stem cell populations to be maintained: increase in cellular mass, mitosis and self-renewal. Since Stat92E is a transcription factor, discrete Stat92E target genes should mediate its effects on these processes. Three such genes with human homologs, cyclin E (cycE), dmyc and chinmo, appear to reside directly downstream of Stat92E. CycE is the rate-limiting regulator of the cell cycle and its expression is increased by Stat92E in a cell- autonomous manner. dMyc is the sole c-Myc family member in Drosophila and is a critical regulator of cellular growth. Stat92E increases protein synthesis and may act through dMyc to do so. chinmo encodes a novel nuclear protein and is regulated by Stat92E in a cell-autonomous manner. Like Stat92E, Chinmo is required within testis stem cells for their self-renewal. The identification of Stat92E-regulated targets with links to mitosis, cellular growth and self-renewal is a major advance in our understanding of the growth-regulatory properties of the JAK/STAT pathway. Aim 1 (Characterize the effects of JAK/STAT signaling on proliferation) employs molecular methods and FACS analysis to measure the effects of JAK/STAT signaling on proliferation rates, cell cycle phasing and expression of critical cell cycle factors. Aim 2 (Determine if Stat92E regulates cellular growth through dMyc) uses genetic approaches and FACS analysis to measure the effects of Stat92E on cellular growth and to determine if it regulates this process through dmyc. Aim 3 (Determine if Stat92E regulates self-renewal in through chinmo) uses genetic and molecular approaches to determine if Stat92E regulates self-renewal in testis stem cells through chinmo alone or through additional target genes. PUBLIC HEALTH RELEVANCE Due to evolution, JAK and STAT genes exist in very similar forms in other organisms, such as the fruit fly Drosophila. The fruit fly is an excellent genetic organism that has been used for many years in research laboratories and with great success to identify and characterize genes critical for basic biological processes. Our study is designed to eludicate how the JAK/STAT pathway regulates stem cell numbers in Drosophila.
描述(由申请人提供):控制干细胞自我更新与分化的分子机制对癌症生物学、衰老和再生医学的进展具有巨大潜力。增加干细胞库为肿瘤发生提供了条件;肿瘤具有自我更新和建立转移的“癌症干细胞”。哺乳动物中干细胞数量的关键调节因子是JAK/STAT途径。哺乳动物JAK和STAT的不适当激活会导致癌症,抑制它们的活性会阻断原代人类癌细胞的生长。这些数据表明,开发特异性抑制JAK或STAT的药物可以为癌症患者提供新的治疗方法。尽管有这些令人信服的观察结果,但该途径用于调节哺乳动物干细胞数量的机制尚未阐明。哺乳动物有多个jak和stat基因,这使得分析它们的体内功能变得困难。果蝇提供了一个解决这个问题的理想系统,因为它对干细胞数量的控制在几个组织中是保守的,包括睾丸和眼睛。果蝇只有一个jak和一个stat(称为stat 92 E),并提供简单的体内分析。本申请涉及JAK/STAT途径用于调节果蝇干细胞数量的分子机制的解剖。三个不同的过程必须以协调的方式发生,以维持干细胞群:细胞质量的增加,有丝分裂和自我更新。由于Stat 92 E是一个转录因子,离散Stat 92 E靶基因应介导其对这些过程的影响。与人类同源的三个这样的基因,细胞周期蛋白E(cycE),dmyc和chinmo,似乎直接位于Stat 92 E的下游。CycE是细胞周期的限速调节剂,其表达通过Stat 92 E以细胞自主方式增加。dMyc是果蝇中唯一的c-Myc家族成员,是细胞生长的关键调节因子。Stat 92 E增加蛋白质合成,并可能通过dMyc发挥作用。chinmo编码一种新型核蛋白,并受Stat 92 E以细胞自主方式调节。与Stat 92 E一样,Chinmo也是睾丸干细胞自我更新所必需的。Stat 92 E调控的靶点与有丝分裂,细胞生长和自我更新的联系的鉴定是我们对JAK/STAT途径生长调节特性的理解的一个重大进展。目的1(表征JAK/STAT信号传导对增殖的影响)采用分子方法和流式细胞仪分析来测量JAK/STAT信号传导对增殖速率、细胞周期定相和关键细胞周期因子表达的影响。目的2(确定Stat 92 E是否通过dMyc调节细胞生长)使用遗传方法和FACS分析来测量Stat 92 E对细胞生长的影响,并确定其是否通过dMyc调节该过程。目的3(确定Stat 92 E是否通过chinmo调节自我更新)使用遗传和分子方法来确定Stat 92 E是否通过单独的chinmo或通过其他靶基因调节睾丸干细胞的自我更新。 由于进化,JAK和STAT基因在其他生物中以非常相似的形式存在,例如果蝇。果蝇是一种优秀的遗传生物,多年来一直被用于研究实验室,并在识别和表征基本生物过程的关键基因方面取得了巨大成功。我们的研究旨在阐明JAK/STAT通路如何调节果蝇干细胞数量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Erika A Bach其他文献

Erika A Bach的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Erika A Bach', 18)}}的其他基金

Somatic control of germline differentiation in spermatogenesis.
精子发生中种系分化的体细胞控制。
  • 批准号:
    10741641
  • 财政年份:
    2023
  • 资助金额:
    $ 35.39万
  • 项目类别:
Characterization of age-related changes in spermatogonial dedifferentiation
精原去分化的年龄相关变化的表征
  • 批准号:
    10380887
  • 财政年份:
    2021
  • 资助金额:
    $ 35.39万
  • 项目类别:
Characterization of age-related changes in spermatogonial dedifferentiation
精原去分化的年龄相关变化的表征
  • 批准号:
    10215936
  • 财政年份:
    2021
  • 资助金额:
    $ 35.39万
  • 项目类别:
Uncovering mechanisms controlling germline stem cell competition
揭示控制生殖干细胞竞争的机制
  • 批准号:
    9454752
  • 财政年份:
    2017
  • 资助金额:
    $ 35.39万
  • 项目类别:
Eludicating the Molecular Mechanisms That Regulate Stem Cell Numbers in Vivo
阐明体内调节干细胞数量的分子机制
  • 批准号:
    8665741
  • 财政年份:
    2013
  • 资助金额:
    $ 35.39万
  • 项目类别:
JAK/STAT PATHWAY CONTROL OF CELL COMPETITION DURING DEVELOPMENT.
发育过程中细胞竞争的 JAK/STAT 通路控制。
  • 批准号:
    8665757
  • 财政年份:
    2013
  • 资助金额:
    $ 35.39万
  • 项目类别:
Training in Pharmacological Sciences
药理学培训
  • 批准号:
    8675318
  • 财政年份:
    2013
  • 资助金额:
    $ 35.39万
  • 项目类别:
JAK/STAT PATHWAY CONTROL OF CELL COMPETITION DURING DEVELOPMENT.
发育过程中细胞竞争的 JAK/STAT 通路控制。
  • 批准号:
    8443380
  • 财政年份:
    2012
  • 资助金额:
    $ 35.39万
  • 项目类别:
JAK/STAT PATHWAY CONTROL OF CELL COMPETITION DURING DEVELOPMENT.
发育过程中细胞竞争的 JAK/STAT 通路控制。
  • 批准号:
    8301395
  • 财政年份:
    2012
  • 资助金额:
    $ 35.39万
  • 项目类别:
ELUCIDATING MECHANISMS OF CELL COMPETITION DURING DEVELOPMENT
阐明发育过程中细胞竞争的机制
  • 批准号:
    10476372
  • 财政年份:
    2009
  • 资助金额:
    $ 35.39万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 35.39万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 35.39万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.39万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.39万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 35.39万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.39万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 35.39万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 35.39万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 35.39万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.39万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了